Edition:
United States

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

439.64USD
4:00pm EDT
Change (% chg)

$-3.51 (-0.79%)
Prev Close
$443.15
Open
$438.62
Day's High
$441.68
Day's Low
$432.07
Volume
432,045
Avg. Vol
280,158
52-wk High
$446.81
52-wk Low
$139.49

Select another date:

Thu, May 3 2018

BRIEF-Abiomed Q4 GAAP EPS $0.80

* ABIOMED ANNOUNCES Q4 FY 2018 REVENUE OF $174 MILLION, UP 40%, AND TOTAL YEAR REVENUE OF $594 MILLION, UP 33%, OVER PRIOR YEAR

BRIEF-Abiomed Reports Q4 GAAP Earnings Per Share $0.80

* ABIOMED ANNOUNCES Q4 FY 2018 REVENUE OF $174 MILLION, UP 40%, AND TOTAL YEAR REVENUE OF $594 MILLION, UP 33%, OVER PRIOR YEAR

BRIEF-Abiomed Announces European Approval For Impella 5.5(Tm)

* ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5(TM) AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG Source text for Eikon: Further company coverage:

BRIEF-Abiomed Announces European Approval (CE Marking) For Impella 5.5™

* ABIOMED ANNOUNCES EUROPEAN APPROVAL (CE MARKING) FOR IMPELLA 5.5™ AND FIRST PATIENT TREATED AT UNIVERSITY HEART CENTER HAMBURG Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Abiomed Receives FDA Approval For Impella Cp® With Smartassist™ And Optical Sensor

* ABIOMED RECEIVES FDA APPROVAL FOR IMPELLA CP® WITH SMARTASSIST™ AND OPTICAL SENSOR

BRIEF-Abiomed To Appoint Todd Trapp Chief Financial Officer

* ABIOMED TO APPOINT NEW CHIEF FINANCIAL OFFICER TODD A. TRAPP

Abiomed to pay $3.1 million to settle case over lavish doctor meals

BOSTON Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. probe into allegations that it sought to get doctors to use a line of heart pumps it produced by buying them lavish meals at some of the most expensive restaurants in the United States.

UPDATE 2-Abiomed to pay $3.1 mln to settle case over lavish doctor meals

BOSTON, March 8 Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. probe into allegations that it sought to get doctors to use a line of heart pumps it produced by buying them lavish meals at some of the most expensive restaurants in the United States.

BRIEF-Abiomed Says Entered Settlement With U.S. DoJ Resolving Claims Related To Employee Meals

* ABIOMED - ON MARCH 6, ENTERED SETTLEMENT WITH U.S. DOJ RESOLVING CLAIMS ON CO'S REIMBURSEMENT OF EMPLOYEE EXPENSES FOR MEALS WITH HEALTHCARE PROVIDERS Source text: (http://bit.ly/2G9t6b6) Further company coverage:

Heart pump maker Abiomed settles U.S. kickback probe for $3.1 mln

BOSTON, March 8 Abiomed Inc has agreed to pay $3.1 million to resolve a U.S. investigation into allegations that it sought to induce doctors into using a line of heart pumps it produced by buying them lavish meals.

Select another date: